Zydus Lifesciences posts strong Q3 FY25 results with 30% net profit surge

Pallavi Madhiraju- February 5, 2025 0

Zydus Lifesciences Limited has reported robust financial performance for the third quarter of fiscal year 2025, driven by strong revenue growth momentum, expansion in key ... Read More

Zydus Lifesciences chairman Pankaj Patel honoured with Padma Bhushan

Pallavi Madhiraju- January 26, 2025 0

In a proud moment for the Indian lifesciences industry, Pankaj R. Patel, Chairman of Zydus Lifesciences Limited, has been awarded the prestigious Padma Bhushan. Conferred ... Read More

Zydus Lifesciences gets FDA approval for Phase 2b ALS trial of Usnoflast

Pallavi Madhiraju- January 19, 2025 0

Zydus Lifesciences, a global leader in pharmaceutical innovation, has received approval from the United States Food and Drug Administration (USFDA) to commence Phase II(b) clinical ... Read More

Zydus Lifesciences bags FDA approval for Fludrocortisone Acetate Tablets, boosting U.S. market presence

Pallavi Madhiraju- October 17, 2024 0

Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) to produce Fludrocortisone Acetate Tablets USP, 0.1 mg, according ... Read More

Zydus Lifesciences launches fight against prostate cancer with new FDA-approved drug enzalutamide

Pallavi Madhiraju- September 29, 2024 0

Zydus Lifesciences Limited has achieved a significant milestone in the pharmaceutical industry. The company recently received final approval from the United States Food and Drug ... Read More

Zydus and CSIR-CDRI launch collaborative research for new CKD-induced osteoporosis treatment

Pallavi Madhiraju- September 28, 2024 0

Zydus Lifesciences Ltd and CSIR-Central Drug Research Institute (CDRI) have joined forces to develop an innovative drug targeting osteoporosis induced by chronic kidney disease (CKD). ... Read More

Zydus Lifesciences wins FDA approval for Amantadine Capsules, secures 180-day exclusivity

Pallavi Madhiraju- August 27, 2024 0

Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has achieved a significant regulatory milestone by receiving final approval from the United States Food and ... Read More

Zydus Lifesciences to acquire 50% stake in Sterling Biotech from Perfect Day to expand into sustainable protein market

Pallavi Madhiraju- August 24, 2024 0

Zydus Lifesciences Limited, a major player in the global pharmaceutical industry, has entered a pivotal partnership by acquiring a 50% stake in Sterling Biotech Limited ... Read More

Game-changing MRI technology: Zynext Ventures bets big on Neuro42’s brain imaging

Pallavi Madhiraju- August 15, 2024 0

Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences, has made a significant investment in Neuro42 Inc., a US-based company specialising in advanced ... Read More

Zydus Lifesciences receives tentative FDA approval for Azilsartan Medoxomil Tablets

Pallavi Madhiraju- July 4, 2024 0

Zydus Lifesciences Limited has achieved a significant milestone with the tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil ... Read More

123...810 / 80 Posts